SCHEMBL22761306

SCHEMBL22761306

NNc1nc(-c2ccncc2)no1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.51
NPC1 O15118 12/20 0.50
RAB9A P51151 12/20 0.50
NPSR1 Q6W5P4 2/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 4/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49
RELA Q04206 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
LMNA P02545 3/20 0.47
GAA P10253 1/20 0.47
NOTUM Q6P988 1/20 0.47
CA2 P00918 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22761301 0.83 NOTUM (0.63) SMN1; SMN2NPC1RAB9ACYP1A2CYP2C19
SCHEMBL2768635 0.80 NOTUM (0.70) SMN1; SMN2NPC1RAB9ANPSR1CYP1A2
SCHEMBL22761276 0.80 NPC1 (0.47) SMN1; SMN2NPC1RAB9AMAPTNOTUM
SCHEMBL22761436 0.80 LMNA (0.54) SMN1; SMN2MAPTLMNAS1PR1
SCHEMBL22761300 0.80 CHRNB2 (0.63) SMN1; SMN2NPC1RAB9ANPSR1MAPT
SCHEMBL22761279 0.76 NPC1 (0.56) SMN1; SMN2NPC1RAB9ANPSR1MAPT
SCHEMBL5959967 0.74 SMN1; SMN2 (0.85) SMN1; SMN2NPC1RAB9ANPSR1MAPT
SCHEMBL22761433 0.73 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ANPSR1CYP1A2
SCHEMBL11038681 0.71 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ANPSR1CYP1A2
SCHEMBL15088383 0.71 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ANPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020247819-A2 METHODS OF TREATMENT WITH AMINOLEVULINIC ACID SYNTHASE 2 (ALAS2) MODULATORS AGIOS PHARMACEUTICALS, INC. (US) 2020-12-10 WO disclosed